Ind-Swift Laboratories Ltd has issued a regulatory notice pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements), 2015.
The Board of Directors meeting is scheduled for Thursday, October 29, 2026. The primary agenda includes consideration, approval, and taking on record the Standalone and Consolidated Un-Audited Financial Results for the quarter and half year ended 30th September, 2026.
The company has previously communicated information regarding the closure of the Trading Window for dealing in the company's securities to the stock exchanges where its shares are listed. This communication was made via letter dated September 28, 2026.
The complete information is available on the company's official website at www.indswiftgroup.com under the Investors section.
The notice is signed by Pardeep Verma, VP-Corporate Affairs & Company Secretary, with digital signature timestamped October 15, 2026 at 18:26:10 +05:30.